Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Fretz

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Bioorganic & Medicinal Chemistry|May 17, 2001
DNA binding properties of the marine sponge pigment fascaplysinA Hörmann, B Chaudhuri, H Fretz
Journal of Computer-Aided Molecular Design|June 8, 2001
Identification of cylin-dependent kinase 1 inhibitors of a new chemical type by structure-based design and database searchingP Furet, T Meyer, P Mittl, et al.
Biochemical and Biophysical Research Communications|June 22, 2000
Novel Cdk inhibitors restore TGF-beta sensitivity in cdk4 overexpressing epithelial cellsR Soni, H Fretz, L Muller, et al.
Current Pharmaceutical Design|December 5, 2000
Structure-based design of compounds inhibiting Grb2-SH2 mediated protein-protein interactions in signal transduction pathwaysH Fretz, P Furet, C Garcia-Echeverria, et al.
Bioorganic & Medicinal Chemistry|July 1, 1996
The substrate specificity of tocopherol cyclaseA Stocker, H Fretz, H Frick, et al.
European Journal of Biochemistry|April 2, 1999
Aspects of the molecular structure and dynamics of neuropeptide YA Nordmann, M J Blommers, H Fretz, et al.
Bioorganic & Medicinal Chemistry Letters|February 18, 1999
Highly potent inhibitors of the Grb2-SH2 domainJ Schoepfer, H Fretz, B Gay, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Structure-based design of peptidomimetic ligands of the Grb2-SH2 domainJ Schoepfer, B Gay, G Caravatti, et al.
Journal of Medicinal Chemistry|November 14, 1997
Discovery of 3-aminobenzyloxycarbonyl as an N-terminal group conferring high affinity to the minimal phosphopeptide sequence recognized by the Grb2-SH2 domainP Furet, B Gay, C García-Echeverría, et al.
Journal of Medicinal Chemistry|June 20, 1998
Potent antagonists of the SH2 domain of Grb2: optimization of the X+1 position of 3-amino-Z-Tyr(PO3H2)-X+1-Asn-NH2C García-Echeverría, P Furet, B Gay, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Bioorganic & Medicinal Chemistry|May 17, 2001
DNA binding properties of the marine sponge pigment fascaplysinA Hörmann, B Chaudhuri, H Fretz
Journal of Computer-Aided Molecular Design|June 8, 2001
Identification of cylin-dependent kinase 1 inhibitors of a new chemical type by structure-based design and database searchingP Furet, T Meyer, P Mittl, et al.
Biochemical and Biophysical Research Communications|June 22, 2000
Novel Cdk inhibitors restore TGF-beta sensitivity in cdk4 overexpressing epithelial cellsR Soni, H Fretz, L Muller, et al.
Current Pharmaceutical Design|December 5, 2000
Structure-based design of compounds inhibiting Grb2-SH2 mediated protein-protein interactions in signal transduction pathwaysH Fretz, P Furet, C Garcia-Echeverria, et al.
Bioorganic & Medicinal Chemistry|July 1, 1996
The substrate specificity of tocopherol cyclaseA Stocker, H Fretz, H Frick, et al.
European Journal of Biochemistry|April 2, 1999
Aspects of the molecular structure and dynamics of neuropeptide YA Nordmann, M J Blommers, H Fretz, et al.
Bioorganic & Medicinal Chemistry Letters|February 18, 1999
Highly potent inhibitors of the Grb2-SH2 domainJ Schoepfer, H Fretz, B Gay, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Structure-based design of peptidomimetic ligands of the Grb2-SH2 domainJ Schoepfer, B Gay, G Caravatti, et al.
Journal of Medicinal Chemistry|November 14, 1997
Discovery of 3-aminobenzyloxycarbonyl as an N-terminal group conferring high affinity to the minimal phosphopeptide sequence recognized by the Grb2-SH2 domainP Furet, B Gay, C García-Echeverría, et al.
Journal of Medicinal Chemistry|June 20, 1998
Potent antagonists of the SH2 domain of Grb2: optimization of the X+1 position of 3-amino-Z-Tyr(PO3H2)-X+1-Asn-NH2C García-Echeverría, P Furet, B Gay, et al.
Pageof 2